Pinonggan, Savilla S.
HRN: 24-37-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/04/2024
07/11/2024
IV
4.5
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes